ALK and lymphoma: As a possible explanation for these findings, combined treatment abolished the phosphorylation of IGF-IR and NPM-ALK as well as the phosphorylation of their common downstream target STAT3; a major survival-promoting transcription factor in this lymphoma [11, 12, 48].